ES2757909T3 - Analisis de compensación que incluye señales segmentadas - Google Patents

Analisis de compensación que incluye señales segmentadas Download PDF

Info

Publication number
ES2757909T3
ES2757909T3 ES17206329T ES17206329T ES2757909T3 ES 2757909 T3 ES2757909 T3 ES 2757909T3 ES 17206329 T ES17206329 T ES 17206329T ES 17206329 T ES17206329 T ES 17206329T ES 2757909 T3 ES2757909 T3 ES 2757909T3
Authority
ES
Spain
Prior art keywords
function
sample
error
residual
compensation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17206329T
Other languages
English (en)
Spanish (es)
Inventor
Huan-Ping Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ascensia Diabetes Care Holdings AG
Original Assignee
Ascensia Diabetes Care Holdings AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ascensia Diabetes Care Holdings AG filed Critical Ascensia Diabetes Care Holdings AG
Application granted granted Critical
Publication of ES2757909T3 publication Critical patent/ES2757909T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3274—Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Electrochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
ES17206329T 2011-09-21 2012-09-20 Analisis de compensación que incluye señales segmentadas Active ES2757909T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161537145P 2011-09-21 2011-09-21

Publications (1)

Publication Number Publication Date
ES2757909T3 true ES2757909T3 (es) 2020-04-30

Family

ID=47881000

Family Applications (2)

Application Number Title Priority Date Filing Date
ES17206329T Active ES2757909T3 (es) 2011-09-21 2012-09-20 Analisis de compensación que incluye señales segmentadas
ES12779189.5T Active ES2663097T3 (es) 2011-09-21 2012-09-20 Biosensor con compensación de error

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES12779189.5T Active ES2663097T3 (es) 2011-09-21 2012-09-20 Biosensor con compensación de error

Country Status (8)

Country Link
US (2) US9775806B2 (enExample)
EP (3) EP3586831A1 (enExample)
JP (1) JP6082396B2 (enExample)
KR (1) KR20140063829A (enExample)
ES (2) ES2757909T3 (enExample)
MX (1) MX350696B (enExample)
TW (1) TWI600892B (enExample)
WO (1) WO2013043839A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2550530A1 (en) * 2010-03-22 2013-01-30 Bayer HealthCare LLC Residual compensation for a biosensor
US9933441B2 (en) 2013-03-14 2018-04-03 Ascensia Diabetes Care Holdings Ag Progressive approximation of sample analyte concentration
CN105283765B (zh) 2013-03-14 2018-01-16 安晟信医疗科技控股公司 分析物浓度测定的系统误差补偿
HK1221771A1 (zh) * 2013-03-14 2017-06-09 安晟信医疗科技控股公司 分析物浓度测定的标准化校准
US10551362B2 (en) 2013-03-26 2020-02-04 Waters Technologies Corporation Method for extending the dynamic range of absorbance detectors
GB2531728A (en) 2014-10-27 2016-05-04 Cilag Gmbh Int Method for determining diffusion
EP3295159B1 (en) 2015-05-15 2021-12-01 Ascensia Diabetes Care Holdings AG Improved biosensor system analyte measurement
CN109690304A (zh) * 2016-07-12 2019-04-26 安晟信医疗科技控股公司 通过使用来自两个电极的交替输出信号进行电化学分析的方法
EP3548881A1 (en) * 2016-12-05 2019-10-09 Ascensia Diabetes Care Holdings AG Risk factor monitoring
CN113167760B (zh) * 2018-12-02 2023-11-03 聚合物技术系统公司 用于电化学测试条带中的电子门特征的系统和方法
JP7494194B2 (ja) 2019-02-05 2024-06-03 アセンシア・ディアベティス・ケア・ホールディングス・アーゲー 連続的分析物感知および自動較正のセンサ動作を精査するための装置および方法
EP3928089B1 (en) 2019-02-22 2025-05-14 Ascensia Diabetes Care Holdings AG Method and system for glucose concentration monitoring using harmonic relationships
CN109884150B (zh) * 2019-03-08 2021-05-14 武汉璟泓科技股份有限公司 一种红细胞积压校正方法及存储介质
US11963763B2 (en) 2019-09-10 2024-04-23 Ascensia Diabetes Care Holdings Ag Methods and apparatus information gathering, error detection and analyte concentration determination during continuous analyte sensing
CN112432988B (zh) * 2020-11-25 2023-03-03 重庆迈联医疗科技有限公司 电化学测试系统的温度校正方法
CN114777888B (zh) * 2022-04-28 2024-09-20 四川泛华航空仪表电器有限公司 一种基于光纤光栅压力传感器液位测量误差补偿修正方法
CN119224239B (zh) * 2024-12-02 2025-04-18 无锡零界净化设备股份有限公司 一种用于离线式浓度监测仪的信号增强方法及平台
CN121409898B (zh) * 2025-12-05 2026-07-24 湖南云河信息科技有限公司 基于标准液稀释曲线的在线光谱检测补偿方法、设备及系统

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431004A (en) 1981-10-27 1984-02-14 Bessman Samuel P Implantable glucose sensor
US4750496A (en) 1987-01-28 1988-06-14 Xienta, Inc. Method and apparatus for measuring blood glucose concentration
US5243516A (en) 1989-12-15 1993-09-07 Boehringer Mannheim Corporation Biosensing instrument and method
US5508171A (en) 1989-12-15 1996-04-16 Boehringer Mannheim Corporation Assay method with enzyme electrode system
FR2701117B1 (fr) 1993-02-04 1995-03-10 Asulab Sa Système de mesures électrochimiques à capteur multizones, et son application au dosage du glucose.
US5366609A (en) 1993-06-08 1994-11-22 Boehringer Mannheim Corporation Biosensing meter with pluggable memory key
US5352351A (en) 1993-06-08 1994-10-04 Boehringer Mannheim Corporation Biosensing meter with fail/safe procedures to prevent erroneous indications
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
US6153069A (en) 1995-02-09 2000-11-28 Tall Oak Ventures Apparatus for amperometric Diagnostic analysis
US5582697A (en) 1995-03-17 1996-12-10 Matsushita Electric Industrial Co., Ltd. Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same
US5620579A (en) 1995-05-05 1997-04-15 Bayer Corporation Apparatus for reduction of bias in amperometric sensors
US5723284A (en) 1996-04-01 1998-03-03 Bayer Corporation Control solution and method for testing the performance of an electrochemical device for determining the concentration of an analyte in blood
AU6157898A (en) 1997-02-06 1998-08-26 E. Heller & Company Small volume (in vitro) analyte sensor
US6391558B1 (en) 1997-03-18 2002-05-21 Andcare, Inc. Electrochemical detection of nucleic acid sequences
US5798031A (en) 1997-05-12 1998-08-25 Bayer Corporation Electrochemical biosensor
US6391645B1 (en) 1997-05-12 2002-05-21 Bayer Corporation Method and apparatus for correcting ambient temperature effect in biosensors
EP0990151A2 (en) 1997-06-16 2000-04-05 ELAN CORPORATION, Plc Methods of calibrating and testing a sensor for (in vivo) measurement of an analyte and devices for use in such methods
HU222809B1 (hu) 1997-10-03 2003-10-28 77 Elektronika Műszeripari Kft. Eljárás és készülék kémiai összetevőnek anyagmintából, különösen vér glükóztartalmának vérmintából történő meghatározásához
JP3260739B2 (ja) 1997-12-22 2002-02-25 ロシュ ダイアグノスティックス コーポレーション 生物学的流体の医学的に有意な成分の濃度を測定する装置および方法
US7494816B2 (en) * 1997-12-22 2009-02-24 Roche Diagnostic Operations, Inc. System and method for determining a temperature during analyte measurement
US6233471B1 (en) 1998-05-13 2001-05-15 Cygnus, Inc. Signal processing for measurement of physiological analysis
AU3849799A (en) 1998-05-20 1999-12-06 Arkray, Inc. Method and apparatus for electrochemical measurement using statistical technique
US6475372B1 (en) 2000-02-02 2002-11-05 Lifescan, Inc. Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations
CA2305922C (en) 1999-08-02 2005-09-20 Bayer Corporation Improved electrochemical sensor design
WO2001021827A1 (en) 1999-09-20 2001-03-29 Roche Diagnostics Corporation Small volume biosensor for continuous analyte monitoring
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
JP4050434B2 (ja) 1999-11-29 2008-02-20 松下電器産業株式会社 サンプルの弁別方法
WO2002057768A1 (fr) 2001-01-17 2002-07-25 Arkray, Inc. Procede d'analyse quantitative et dispositif d'analyse quantitative utilisant un capteur
US6541266B2 (en) 2001-02-28 2003-04-01 Home Diagnostics, Inc. Method for determining concentration of an analyte in a test strip
US6562625B2 (en) 2001-02-28 2003-05-13 Home Diagnostics, Inc. Distinguishing test types through spectral analysis
AU784254B2 (en) 2001-05-21 2006-03-02 Bayer Corporation Improved electrochemical sensor
US6982178B2 (en) 2002-06-10 2006-01-03 E Ink Corporation Components and methods for use in electro-optic displays
US6797150B2 (en) 2001-10-10 2004-09-28 Lifescan, Inc. Determination of sample volume adequacy in biosensor devices
JP4246633B2 (ja) 2001-10-12 2009-04-02 アークレイ株式会社 濃度測定方法および濃度測定装置
CA2419213C (en) 2002-03-07 2011-06-21 Bayer Healthcare Llc Improved electrical sensor
US6946299B2 (en) 2002-04-25 2005-09-20 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
US6964871B2 (en) 2002-04-25 2005-11-15 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
AU2003234944A1 (en) 2002-08-27 2004-03-18 Bayer Healthcare, Llc Methods of Determining Glucose Concentration in Whole Blood Samples
US7132041B2 (en) 2003-02-11 2006-11-07 Bayer Healthcare Llc Methods of determining the concentration of an analyte in a fluid test sample
US7452457B2 (en) 2003-06-20 2008-11-18 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
US7488601B2 (en) 2003-06-20 2009-02-10 Roche Diagnostic Operations, Inc. System and method for determining an abused sensor during analyte measurement
ES2709991T3 (es) 2003-08-21 2019-04-22 Agamatrix Inc Método y aparato para el análisis de propiedades electroquímicas
JP4449431B2 (ja) 2003-11-19 2010-04-14 パナソニック株式会社 基質濃度の測定方法
RU2371707C2 (ru) 2004-02-06 2009-10-27 БАЙЕР ХЕЛТКЭР ЭлЭлСи Электрохимический биодатчик
JP4689601B2 (ja) 2004-04-19 2011-05-25 パナソニック株式会社 血液成分の測定方法、それに用いるバイオセンサおよび測定装置
RU2006144458A (ru) 2004-05-14 2008-06-20 БАЙЕР ХЕЛТКЭР ЭлЭлСи (US) Способы осуществления корректировки по гематокриту в анализах глюкозы и устройства для этого
AU2005295106B2 (en) 2004-10-12 2012-03-15 Bayer Healthcare Llc Concentration determination in a diffusion barrier layer
GB0428547D0 (en) 2004-12-31 2005-02-09 Euroflow Uk Ltd Methods and apparatus for observing vessel contents
GB0501826D0 (en) 2005-01-28 2005-03-09 Melys Diagnostics Ltd Apparatus for measurement of analyte concentration
PL2267150T3 (pl) 2005-04-08 2016-03-31 Bayer Healthcare Llc Utlenialne związki chemiczne jako wzorzec wewnętrzny w roztworach kontrolnych do bioczujników
US7517439B2 (en) 2005-04-15 2009-04-14 Agamatrix, Inc. Error detection in analyte measurements based on measurement of system resistance
EP3483599A1 (en) 2005-07-20 2019-05-15 Ascensia Diabetes Care Holdings AG Methods for measuring the concentration of an analyte in solution and for calibrating the measurement as well as handheld devices therefor
CN103048442B (zh) 2005-09-30 2015-04-08 拜尔健康护理有限责任公司 门控伏特安培法
RU2455925C2 (ru) * 2006-02-27 2012-07-20 БАЙЕР ХЕЛТКЭА ЭлЭлСи Определение исследуемого вещества с поправкой на температуру для систем биодатчиков
US7966859B2 (en) 2006-05-03 2011-06-28 Bayer Healthcare Llc Underfill detection system for a biosensor
JP5121822B2 (ja) 2006-05-08 2013-01-16 バイエル・ヘルスケア・エルエルシー バイオセンサ用異常出力検出システム
CN101495855B (zh) 2006-07-05 2013-04-17 松下电器产业株式会社 液体试样测定方法及装置
US20080248581A1 (en) 2007-04-06 2008-10-09 Bayer Healthcare Llc Method for performing correction of blood glucose assay bias using blood hemoglobin concentration
TWI453401B (zh) 2007-07-26 2014-09-21 Nipro Diagnostics Inc 使用時間解析電流測定法之用於分析物濃度測定的系統及方法(一)
US8101062B2 (en) 2007-07-26 2012-01-24 Nipro Diagnostics, Inc. System and methods for determination of analyte concentration using time resolved amperometry
RU2706691C2 (ru) * 2007-12-10 2019-11-20 Асцензия Диабетс Кэар Холдингс АГ Способ определения концентрации аналита
RU2509304C2 (ru) 2008-12-08 2014-03-10 БАЙЕР ХЕЛТКЭА ЭлЭлСи Биосенсорная система с корректировкой сигнала
WO2011059670A1 (en) 2009-11-10 2011-05-19 Bayer Healthcare Llc Underfill recognition system for a biosensor
KR102068949B1 (ko) 2010-06-07 2020-01-21 바이엘 헬쓰케어 엘엘씨 2차 출력 신호를 포함하는 기울기-기반 보상

Also Published As

Publication number Publication date
TW201314195A (zh) 2013-04-01
US20130071869A1 (en) 2013-03-21
MX350696B (es) 2017-09-14
EP2758039A1 (en) 2014-07-30
JP6082396B2 (ja) 2017-02-15
US9775806B2 (en) 2017-10-03
KR20140063829A (ko) 2014-05-27
EP3315123A1 (en) 2018-05-02
EP3586831A1 (en) 2020-01-01
JP2014527186A (ja) 2014-10-09
WO2013043839A1 (en) 2013-03-28
EP3315123B1 (en) 2019-08-21
US10646445B2 (en) 2020-05-12
MX2014003015A (es) 2014-05-07
TWI600892B (zh) 2017-10-01
EP2758039B1 (en) 2018-01-24
US20170360712A1 (en) 2017-12-21
ES2663097T3 (es) 2018-04-11

Similar Documents

Publication Publication Date Title
ES2663097T3 (es) Biosensor con compensación de error
US10921278B2 (en) Slope-based compensation including secondary output signals
RU2455925C2 (ru) Определение исследуемого вещества с поправкой на температуру для систем биодатчиков
JP6002274B2 (ja) 信号調整を持つバイオセンサシステム
CN103003692B (zh) 用于生物传感器的剩余补偿
ES2812806T3 (es) Calibración normalizada de determinaciones de la concentración de analito
JP7066649B2 (ja) 分析物濃度決定のシステム誤差補償
JP2012511160A5 (enExample)
JP2016517517A5 (enExample)
ES2715407T3 (es) Aproximación progresiva de la concentración de un analito de muestra
ES2697000T3 (es) Compensación basada en pendiente